Anti-CD47 antibody trial in advanced cancers shows treatment appears safe, well-tolerated - Scope

Medicine

Anti-CD47 antibody trial in advanced cancers shows treatment appears safe, well-tolerated - Scope

stanford.edu - Krista Conger

Over the years, I've written quite a bit about a protein called CD47 that is found on the surface of many types of cancer cells, as well as on aging …

View on stanford.edu